Nippon India NIFTY Pharma ETF Growth Plan

PHARMABEES06 Dec 2024
ETF
₹
-0.06 (-0.26%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
BUY
SELL
To Invest in Nippon India NIFTY Pharma ETF Growth Plan
Nippon India NIFTY Pharma ETF Growth Plan
ETF
PHARMABEES06 Dec 2024
₹
-0.06 (-0.26%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Nippon India NIFTY Pharma ETF Growth Plan - Share Price & Details

Traded Volume
₹
Market Cap(Cr)
Avg Traded Price
1 Year return
39.55%
Upper Circuit
Lower Circuit
P/E TTM
0
P/B Ratio
2.19
Traded Value(Cr)
0.00
EPS TTM
0
Book value
Dividend
0.00%

Invest in Nippon India NIFTY Pharma ETF Growth Plan at ZERO Brokerage for 30 days

Price Performance

0.97 %
1 Wk
-1.80 %
1 M
-2.72 %
3 M
39.55 %
1 Y
33.61 %
YTD

Traded Volume Movement

Technical Details

Support 3
23
Support 2
23
Support 1
23
Pivot Point :
24
Resistance 1
24
Resistance 2
24
Resistance 3
24

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Nippon India NIFTY Pharma ETF Growth Plan
₹22.90(-0.06/-0.26%)
22.90-0.06759.7839.550.002.19
Motilal Oswal NASDAQ 100 ETF
₹179.85(-1.81/-1.00%)
179.85-1.819,152.2938.760.0097.59
Motilal Oswal Midcap 100 ETF
₹62.86(+0.26/0.42%)
62.86+0.26459.8533.290.006.28
Nippon India ETF NIFTY 100
₹269.74(+2.70/1.01%)
269.74+2.70247.8022.750.0013.98
LIC MF Gold ETF
₹6,941.40(-9.05/-0.13%)
6,941.40-9.05136.7322.280.001.43
Aditya Birla Sun Life Nifty 50 ETF
₹28.34(-0.02/-0.07%)
28.34-0.022,424.0919.080.0025.50

About Nippon India NIFTY Pharma ETF Growth Plan

Nippon India NIFTY Pharma ETF Growth Plan is in the ETF sector, having a market capitalization of Rs. 759.78 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes ,  (Nippon India NIFTY Pharma ETF Growth Plan) among others.
Chairman
Registered office
4th Floor Tower A Peninsula Bu,Ganapatrao Kadam Marg Lower Pa,Mumbai,Maharashtra,400013
FAX :91-22-6808 7097
Background
Incorporation Year
Face Value₹0
Market Lot1

Latest News

Bajaj Healthcare get approval from Australian agency for manufacturing site

Bajaj Healthcare's API manufacturing site in Savli, Vadodara, Gujarat, has received approval from the Therapeutic Goods Administration (TGA) of Australia.This site, already approved by the USFDA and the European Union, is now authorised to supply active pharmaceutical ingredients (APIs) directly to the Australian and New Zealand markets. The approval is valid for 24 months.
07 Dec 2024 | 12:44 PM

Multibagger SME IPO turns ₹1.40 lakh to ₹5.49 lakh in two years

Bonus shares, stock split effect: Investing in stocks is like investing in a business. Rhetan TMT shares, listed on the BSE SME platform in 2022, declared a 1:10 stock split and 11:4 bonus shares in 2023, resulting in a significant increase in shareholding from 2000 to 25,500, and a surge in value from ₹1.40 lakh to ₹5.49 lakh.
07 Dec 2024 | 12:01 PM

8 stocks nearing ex-dates for dividend, bonus, split next week

Shareholders who purchase the stock at least one day before the ex-date are eligible for dividends, as the settlement occurs the following day. However, those buying the stock on the ex-date will not qualify for dividends, splits, bonus issues, or similar benefits. Exxaro Tiles and other companies will be in focus next week as they approach record dates for dividends, bonus issues & stock splits.
07 Dec 2024 | 12:00 PM

Traders ramp up bets on December fed cut after mixed jobs data

US Treasuries rallied and traders boosted their bets on a Federal Reserve interest-rate reduction this month after a mixed November employment report. Yields on two-year notes, which are sensitive to central-bank policy changes, slid as much as seven basis points to around 4.08% and retained the bulk of their drop late afternoon in New York.
07 Dec 2024 | 11:28 AM

Roto Rudra wins order for Solar Pumping Solutions across different states

Roto Energy Systems Ltd. has secured over 400 orders for its newly launched Solar Submersible Pumping Systems under brand name "Roto Rudra", reinforcing its position as a key player in sustainable water management globally. The orders span Australia, South Africa, & Indian states of Chhattisgarh & Maharashtra, supporting agriculture, irrigation, & renewable energy initiatives.
07 Dec 2024 | 11:03 AM
view more news

How to buy Nippon India NIFTY Pharma ETF Growth Plan shares on nse?

To buy Nippon India NIFTY Pharma ETF Growth Plan shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Nippon India NIFTY Pharma ETF Growth Plan share price today?

The Nippon India NIFTY Pharma ETF Growth Plan shares price on nse is Rs.22.9 today.

What is the market cap of Nippon India NIFTY Pharma ETF Growth Plan shares on NSE ?

The company has a market capitalization of Rs.759.78Cr

What is the PE & PB ratio of Nippon India NIFTY Pharma ETF Growth Plan shares ?

PE is 0 and PB is 2.19

What is the 52 Week High and Low of Nippon India NIFTY Pharma ETF Growth Plan shares?

Nippon India NIFTY Pharma ETF Growth Plan stock price high: Rs.24.53 Nippon India NIFTY Pharma ETF Growth Plan stock price low: Rs.16.11
BUY
SELL